icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
60th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2009
Back grey_arrow_rt.gif
 
 
 
A Phase 2, Double-Blind, Randomized Study Comparing The Safety of Tenofovir Disoproxil Fumarate (TDF), Emtricitabine Plus TDF (Truvada, TVD) and Entecavir (ETV) in Subjects with Decompensated Chronic Hepatitis B Liver Disease
 
 
  Reported by Jules Levin
AASLD Oct 31-Nov 2 2009, Boston, MA
 
Y-F Liaw1, C-M Lee2, U Akaraca3, G Papatheodoridis4, F Wong5, TT Chang6, A Horban7, C Wang8, P Kwan9, M Buti10, M Prieto11, T Berg12, K Kitrinos13, J Sorbel13, E Mondou13, D Frederick13, F Rousseau13, E Schiff14 Interim 48 Week Data

image002.gif

image004.gif

image006.gif

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif

image026.gif

image028.gif

image030.gif